Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. - Wikidata - awgldk - TriplyDB

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

http://www.wikidata.org/entity/Q34268907

about

Considerations for observational research using large data sets in radiation oncology Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?Radiotherapy for prostate cancer and sexual health Current state of prostate cancer treatment in Jamaica Low temperature plasma: a novel focal therapy for localized prostate cancer?Proton beam therapy: clinical utility and current status in prostate cancer Proton therapy for early stage prostate cancer: is there a case?Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?Misclassification in administrative claims data: quantifying the impact on treatment effect estimates.National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study.Using big data for quality assessment in oncology.Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer.Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.Comparative effectiveness of external-beam radiation approaches for prostate cancer.Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions.Promise and pitfalls of heavy-particle therapy.A snapshot of radiation therapy techniques and technology in Queensland: An aid to mapping undergraduate curriculum The role of focal therapy in the management of localised prostate cancer: a systematic review.Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy Sexual dysfunction and infertility as late effects of cancer treatment.Technology diffusion and prostate cancer quality of care.Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.Model Misspecification When Excluding Instrumental Variables From PS Models in Settings Where Instruments Modify the Effects of Covariates on Treatment A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial.Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.Comparing long-term treatment-associated toxicities in cancer patients: approaches, caveats, and recommendations.Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes.Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer.Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer.Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer.

P2860

Q24289442-B7D5C161-FCA7-44B0-8F24-FB67F45D2F73 Q26749961-D0A7F83B-B1C7-4116-AFFE-94F5D459E48E Q26767399-64D4C68D-DC9D-4045-B8B5-DD266ADF7003 Q26774266-C2DDDAD0-9051-44F3-A404-838B713FD3F6 Q26830148-B9AAEDBC-E7C3-4EAC-AC58-1BCE28C77978 Q27027563-C6A897F4-7711-49E3-A3D1-62B4458940FB Q28070150-5A215E36-B1E8-4488-A2A2-E1C265F148BD Q28072657-FB0D5846-5875-4B41-B4DD-B31ACBE3CB01 Q30300626-9C8448B5-6649-4908-9EE9-47CE7EA099E5 Q30400574-17399C5B-5C94-4069-8349-45E2A74D7C74 Q30413727-43F95FD2-155B-4A82-B525-BF686B529B3E Q30414737-A5DE2108-8434-4D03-B843-59059E21402F Q30428790-0086ACE6-0945-4671-9DDE-88560884DB99 Q30974376-DA140398-B41A-401F-9418-80E76F85F4C3 Q31057376-9C8B8B33-7D76-4DBC-84EF-78C1D35EA4E1 Q31080159-307385A3-6380-4192-A20F-CC6AA8E7904D Q33651525-88F6F743-B4AB-4287-8700-B2F2CEDBF142 Q33774527-9715D4FF-AC59-42CF-95D8-2CFA8ECFB7E4 Q33919002-F330EEC3-005D-493D-A6CA-B83CE049DE6F Q34026731-32EAC26F-0F6F-4ABB-BCDF-B6618770443A Q34031286-EDA35E59-392B-4F66-970C-51C0ECFD27C3 Q34124263-3A056E7A-0370-4FDC-ACBF-5B6EC4636217 Q34247354-F2DEE88A-238E-4A32-9820-1FB069D46EA7 Q34266167-BCD2FF87-47DF-4CD4-A0E1-35CF1351798E Q34500966-34D72970-BE25-4C01-8E36-459C3C217F91 Q34558103-91E47299-1DDB-418E-95AF-FC4CA32CFC81 Q34604454-FB4872F5-114D-41C2-9903-F6DDECC1D2BD Q34626061-4735E208-22FB-47C5-B326-13570FFF57D6 Q35037541-D998A531-2E5B-4444-A980-1953A13284AA Q35056126-E4D79E4E-F014-4B95-B87A-CBA6BF2D2327 Q35202412-20B4E64C-ED9B-41DC-AA46-A1B05899FF07 Q35685540-6B8D11B6-1060-4C9D-B38B-6560A631B0AC Q35812261-B1102174-CF68-4737-9F7A-63793C09A9CF Q36062411-AD1DA91C-DF8A-4B3A-B29E-311982B3A39C Q36072114-61C8C043-5927-4590-B316-C97850225EBE Q36073731-4F0E0350-660D-4B9A-B59E-36956A136979 Q36156751-F3CD9D19-8BC1-49D5-B904-EFC2F6B24D95 Q36387814-8B69AB73-A5D0-4207-AC23-6E2D99804F87 Q36399813-7BDBC2F9-2CDA-40D7-A16C-C9BDD364CB97 Q36446905-3071B93A-6992-49F4-8F56-93D5917A3498

P2860

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

http://www.wikidata.org/entity/Q34268907

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Intensity-modulated radiation ...... in localized prostate cancer.

@ast

Intensity-modulated radiation ...... in localized prostate cancer.

@en

Intensity-modulated radiation ...... in localized prostate cancer.

@nl

type

label

Intensity-modulated radiation ...... in localized prostate cancer.

@ast

Intensity-modulated radiation ...... in localized prostate cancer.

@en

Intensity-modulated radiation ...... in localized prostate cancer.

@nl

prefLabel

Intensity-modulated radiation ...... in localized prostate cancer.

@ast

Intensity-modulated radiation ...... in localized prostate cancer.

@en

Intensity-modulated radiation ...... in localized prostate cancer.

@nl

P1433

Q34268907-930FAF7D-9038-45D0-BBD0-DEAF0367AFC5

P1476

Q34268907-CBF1C399-BA81-45C1-8A68-278F3BA83FDF

P2093

Q34268907-05ABD9D4-E865-4C56-B1E9-300260BE1ADC

Q34268907-2F5C888F-B1EF-4F12-A519-85638CF69A18

Q34268907-4F0CCEC8-EF95-4424-B42C-8EE2B6B84922

Q34268907-79F2095C-725D-41D2-9509-5FF98AFD0470

Q34268907-931DE5E6-2165-4FED-AF0B-90A8252B17F5

Q34268907-A92240CA-4570-4472-A87F-47BC055A7D64

Q34268907-AA7EC63E-FF3F-4125-B227-C292782D8E69

Q34268907-C3402CA0-32BE-4FB1-AB1F-64C8B7B3202E

Q34268907-DA164D50-7D05-4418-874F-96A917D96BA8

Q34268907-F9139190-3CEC-4013-B2ED-5EE5E50610E4

P2860

Q34268907-0864570A-3E4A-4CF1-A051-D67F1909B408

Q34268907-0F325D0F-EDE9-4F34-B904-EC744EA1D8A5

Q34268907-1416E8CA-2C94-4077-9974-E30496837151

Q34268907-24B3B512-F433-4C22-B84D-462734E41C49

Q34268907-33A8BBBD-2307-4B49-8CA8-E8641C9C2DCD

Q34268907-36815585-7414-4FFB-9E8B-D99FA5F2DCBA

Q34268907-3A4E050E-45F7-4A97-8DA5-2CE7EB6D9B14

Q34268907-664F1D23-EBD2-4A3E-BF07-D28474B6170E

Q34268907-77C7802E-9C68-4449-8864-6E5701DA62C6

Q34268907-871CEBF5-BD91-42FF-B985-B39373695165

P304

Q34268907-FCB6BB57-E908-4555-8029-F46E9F1E5EBD

P31

Q34268907-36A8C19C-007F-4403-B544-5D081A86B1F6

P356

Q34268907-AD250F04-8FC7-4B62-9ACB-6D3A15165235

P407

Q34268907-3C15CD2B-6E5D-4CBC-A5E0-29A3162F4C49

P433

Q34268907-AB74630B-E552-4338-A680-7825A83310F3

P478

Q34268907-9441499C-10E0-447B-AFD9-57C11214F4AE

P50

Q34268907-B64D319C-61DA-4018-ABDF-B9D2800D9DFE

P577

Q34268907-6EF5AE5D-2914-4005-8292-B4E0FDC385A5

P5875

Q34268907-F1A27048-911E-4FBA-9C4A-4940F5729889

P698

Q34268907-9D557F7D-9606-4F7A-B2AB-7DA4D42F38AF

P921

Q34268907-541EB679-D3BD-4EBB-8C84-21D5D11A4480

P932

Q34268907-9FA52D0E-802A-4136-B900-1B684F864C63

P356

P1433

Journal of the American Medical Association

P1476

Intensity-modulated radiation ...... in localized prostate cancer.

@en

P2093

Anne-Marie Meyer

http://www.w3.org/2001/XMLSchema#string

Bryce B Reeve

http://www.w3.org/2001/XMLSchema#string

Gregg H Goldin

http://www.w3.org/2001/XMLSchema#string

Jordan A Holmes

http://www.w3.org/2001/XMLSchema#string

Nathan C Sheets

http://www.w3.org/2001/XMLSchema#string

Paul A Godley

http://www.w3.org/2001/XMLSchema#string

Ronald C Chen

http://www.w3.org/2001/XMLSchema#string

William R Carpenter

http://www.w3.org/2001/XMLSchema#string

Yang Wu

http://www.w3.org/2001/XMLSchema#string

YunKyung Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Measuring complications of cancer treatment using the SEER-Medicare data.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes

Instrumental variable methods in comparative safety and effectiveness research

Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

P304

1611-1620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2012.460

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224284993

http://www.w3.org/2001/XMLSchema#string

P698

22511689

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3702170

http://www.w3.org/2001/XMLSchema#string